Literature DB >> 4305674

Recombination between guanidine-resistant and dextran sulfate-resistant mutants of type 1 poliovirus.

D Sergiescu, A Aubert-Combiescu, R Crainic.   

Abstract

Mixed infection of monkey kidney cells with two mutants of the LSc2ab strain of poliovirus, one resistant to guanidine and the other resistant to both dextran sulfate and 2-(alpha-hydroxybenzyl)-benzimidazole (HBB), yielded progeny in which the number of gua(r)dex(r) particles exceeded by a factor of 7 to 10 the expected number of similar particles occurring through spontaneous mutation; recombination would explain the fairly high excess of doubly mutant particles that was obtained. Scoring of HBB resistance in 50 gua(r)dex(r) clones suggested that, during recombination, resistance to dextran sulfate is not associated with HBB resistance.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4305674      PMCID: PMC375771     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  14 in total

1.  CHARACTERS OF GUANIDINE RESISTANT MUTANTS OF TYPE 1 POLIOVIRUS.

Authors:  F HORODNICEANU; D SERGIESCU; R KLEIN; M ZAMFIRESCU; A A COMBIESCU
Journal:  Arch Gesamte Virusforsch       Date:  1964

2.  Genetic recombination with poliovirus type 1. Studies of crosses between a normal horse serum-resistant mutant and several guanidine-resistant mutants of the same strain.

Authors:  N LEDINKO
Journal:  Virology       Date:  1963-05       Impact factor: 3.616

3.  Genetic recombination with Newcastle disease virus, polioviruses, and influenza.

Authors:  G K HIRST
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

4.  A genetic map of poliovirus temperature-sensitive mutants.

Authors:  P D Cooper
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

5.  Mutation towards dextran sulphate resistance in type 1 poliovirus.

Authors:  D Sergiescu; F Horodniceanu; R Crainic
Journal:  Nature       Date:  1967-07-15       Impact factor: 49.962

6.  Genetic transfer of guanidine resistance from type 2 to type 1 poliovirus.

Authors:  D Sergiescu; F Horodniceanu; R Klein; R Crainic
Journal:  Arch Gesamte Virusforsch       Date:  1966

7.  [Probable existence of 2 RNA-replicases in poliovirus].

Authors:  D Ménard; A Lwoff
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1967-05-08

8.  Physiological characterization of heat-defective (temperature-sensitive) poliovirus mutants: preliminary classification.

Authors:  P D Cooper; R T Johnson; D J Garwes
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

9.  Induction with nitrous acid of dextran sulfate resistance in type 1 poliovirus.

Authors:  R Klein; D Sergiescu; M Teodorescu
Journal:  Virology       Date:  1966-09       Impact factor: 3.616

10.  A drug gradient plaque test for the study of the behaviour of animal viruses towards synthetic inhibitors.

Authors:  A Aubert-Combiescu; D Sergiescu; F Horodniceanu
Journal:  Arch Gesamte Virusforsch       Date:  1966
View more
  4 in total

Review 1.  Strength in numbers: Mechanisms of viral co-infection.

Authors:  Elizabeth R Aguilera; Julie K Pfeiffer
Journal:  Virus Res       Date:  2019-03-02       Impact factor: 3.303

2.  Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

Authors:  S Guillot; V Caro; N Cuervo; E Korotkova; M Combiescu; A Persu; A Aubert-Combiescu; F Delpeyroux; R Crainic
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Generated Randomly and Selected Functionally? The Nature of Enterovirus Recombination.

Authors:  Fadi G Alnaji; Kirsten Bentley; Ashley Pearson; Andrew Woodman; Jonathan Moore; Helen Fox; Andrew J Macadam; David J Evans
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

4.  Plaques Formed by Mutagenized Viral Populations Have Elevated Coinfection Frequencies.

Authors:  Elizabeth R Aguilera; Andrea K Erickson; Palmy R Jesudhasan; Christopher M Robinson; Julie K Pfeiffer
Journal:  mBio       Date:  2017-03-14       Impact factor: 7.867

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.